Advanced search×

Advances in clinical research methodology for pain clinical trials.

Nat Med 16(11):1284-93 (2010) PMID 20948532

Pain is a ubiquitous phenomenon, but the experience of pain varies considerably from person to person. Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.

DOI: 10.1038/nm.2249
Version: za2963e q8zad q8zb9 q8zc9 q8zdf q8ze0 q8zf5 q8zg3

Similar articles you may find interesting…

  1. Quantitative clinical pharmacology is transforming drug regulation.

    J Pharmacokinet Biopharm 37(6):617-28 (2010) PMID 20978827

    Prior to 1970s, development and regulation of new drugs was devoid of a fully quantitative, pathophysiological conceptual foundation. Malcolm Rowland pioneered, in collaboration with colleagues and friends, our modern understanding of drug clearance concepts, and equipped drug development and regulat...
  2. Assessment of cancer-related neuropathy and neuropathic pain.

    Oncologist 15(Supplement 2):13-8 (2010) PMID 20489192

    Cancer-related neuropathic pain syndromes are common and serious complications of a patient's primary malignancy or its treatment, whether by surgery, radiation, or chemotherapy. They may compromise the patient's quality of life as well as their ability to receive effective treatment. In many patien...